Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation
Journal:
Current Drug Safety
Volume:
5
Page:
105-111
Author(s):
Guillermo Alberto Keller, Marcelo L. Ponte and Guillermo Di Girolamo
Stem Cells: An Overview of the Current Status of Therapies for Central and Peripheral Nervous System Diseases
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
595-608
Author(s):
A. Orlacchio, G. Bernardi and S. Martino
New Insights into Biological Markers of Frontotemporal Lobar Degeneration Spectrum
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
1002-1009
Author(s):
Barbara Borroni, Antonella Alberici, Silvana Archetti, Enrico Magnani, Monica Di Luca and Alessandro Padovani
Past, Present and Future Therapeutics for Cerebellar Ataxias
Journal:
Current Neuropharmacology
Volume:
8
Page:
41-61
Author(s):
D. Marmolino and M. Manto
Small Heat Shock Proteins and Protein-Misfolding Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
11
Page:
146-157
Author(s):
Ewa Laskowska, Ewelina Matuszewska and Dorota Kuczynska-Wisnik
Clinical Molecular Imaging with PET Agents Other than 18F-FDG
Journal:
Current Pharmaceutical Biotechnology
Volume:
11
Page:
545-554
Author(s):
Lance T. Hall, Aaron F. Struck and Scott B. Perlman
Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
2799-2817
Author(s):
Makoto Naoi and Wakako Maruyama
Magnetic Nanoparticles in Brain Disease Diagnosis and Targeting Drug Delivery
Journal:
Current Nanoscience
Volume:
7
Page:
37-46
Author(s):
Xin Su, Xin Zhan, Fang Tang, Jingyuan Yao and Ji Wu
Role of Nitric Oxide in Motor Control: Implications for Parkinsons Disease Pathophysiology and Treatment
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
471-488
Author(s):
Elaine Del-Bel, Fernando Eduardo Padovan-Neto, Rita Raisman-Vozari and Marcio Lazzarini
The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinsons disease
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
489-507
Author(s):
Rui D. S. Prediger, Aderbal S. Aguiar, Eduardo L. G. Moreira, Filipe C. Matheus, Adalberto A. Castro, Roger Walz, Andreza F. De Bem, Alexandra Latini, Carla I. Tasca, Marcelo Farina and Rita Raisman-Vozari